bioLytical Laboratories Revenue and Competitors
Estimated Revenue & Valuation
- bioLytical Laboratories's estimated annual revenue is currently $30.9M per year.
- bioLytical Laboratories's estimated revenue per employee is $251,000
Employee Data
- bioLytical Laboratories has 123 Employees.
- bioLytical Laboratories grew their employee count by 2% last year.
bioLytical Laboratories's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | VP Quality & Regulatory | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Chief Operating Officer | Reveal Email/Phone |
6 | Director, Information Technology | Reveal Email/Phone |
7 | Chief Scientific Officer | Reveal Email/Phone |
8 | Engineering Manager | Reveal Email/Phone |
9 | Product Launch & Sustaining Manager | Reveal Email/Phone |
10 | Supply Chain Manager | Reveal Email/Phone |
bioLytical Laboratories Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is bioLytical Laboratories?
Biolytical Laboratories Inc. based in Richmond, BC, Canada is a privately-owned Canadian Company federally incorporated in 2002. Our mission is to improve the quality of people's lives by providing innovative solutions for infectious disease diagnosis, the first step in the linkage of patients to appropriate care and treatment. Today, the company sells and markets its INSTI HIV test supported by worldwide regulatory approvals including US FDA approval, Health Canada approval and CE mark in Europe. Our product provides a highly accurate HIV test result in as little as 60 seconds which translates into a compelling value proposition for patients, healthcare professionals, payers and public health organizations. We have an active R&D program and our pipeline includes INSTI tests for diseases such as Hepatitis C and Syphilis. The company also provides contract services to adapt the INSTI platform to meet custom functional and technical diagnostic testing requirements. Our vision is to be a global leader in the research, development and commercialization of rapid, point-of-care in vitro medical diagnostic devices.
keywords:N/AN/A
Total Funding
123
Number of Employees
$30.9M
Revenue (est)
2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
bioLytical Laboratories News
... United Kingdom Ltd., ECO Diagnostica, bioLytical Laboratories, Sedia Biosciences Corporation, Orangelife Com rcio e Ind stria LTDA and WAMA Diagnostica.
Credit: bioLytical Laboratories. Health Canada has granted authorisation to medical diagnostics firm bioLytical Laboratories' iStatis COVID-19...
bioLytical Laboratories Inc. is a privately-owned Canadian company focused on the research, development, and commercialization of rapid in-vitro...
The U.S. FDA guidance in 2001 defined bioanalytical services as ... Inc., Charles River Laboratories International, Inc., Bio-Rad Laboratories, ...
RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in the development and ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.8M | 123 | -6% | $19.1M |
#2 | $17.8M | 123 | 8% | N/A |
#3 | $31.2M | 123 | -4% | N/A |
#4 | $30.1M | 123 | 10% | N/A |
#5 | $17.8M | 123 | 22% | N/A |